Established and suspected biomarkers of cardiovascular disease (CVD) risk in pre-menopausal lebanese women

Ecology of Food and Nutrition

Volumn 47, Issue 3, 2008, Pages 298-311

  Obeid, Omar ^a   Al Khatib, Lynn ^a   Batal, Malek ^a   Adra, Nada ^a   Hwalla, Nahla ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

CVD; Folate; Homocysteine; Nutritional biomarkers; Vitamin B12; Vitamin B6

Indexed keywords

BIOMARKER; CARDIOVASCULAR DISEASE; ENVIRONMENTAL FACTOR; HEALTH RISK; HEALTH STATUS; NUTRITIONAL DISORDER; VITAMIN DEFICIENCY; WOMENS HEALTH;

ASIA; EURASIA; LEBANON; MIDDLE EAST;

EID: 45949109547     PISSN: 03670244     EISSN: 15435237     Source Type: Journal    
DOI: 10.1080/03670240701821337     Document Type: Article

References (40)

1. Abchee, A., Puzantian, H., Azar, S. T., Shbaklo, H., Nasrallah, A., Sawaya, F. J., Alam, S. and Zalloua, P. A. (2006) Predictors of coronary artery disease in the Lebanese population. Thrombosis Research, 117, pp. 631-637.
2. Al-Daghri, N., Chetty, R., McTernan, P. G., Al-Rubean, K., Al-Attas, O. Jones, A. F. et al. (2005) Serum resistin is associated with C-reactive protein & LDL cholesterol in type 2 diabetes and coronary artery disease in a Saudi population. Cardiovascular Diabetology, 4, pp. 10-15.
3. Al Khatib, L., Obeid, O., Dibai, A., Batal, M., Adra, N. and Hwalla, N. (2006) Folate deficiency is associated with nutritional anemia in Lebanese women of childbearing age. Public Health Nutrition, 9, pp. 921-927.
4. American Diabetes Association, (2007) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 30, pp. S42-S47.
5. Arevian, M., Adra, M. and Kubeissi, L. (2004) Risk factors for coronary artery disease (CAD) in Lebanese-Armenian women. Health Care For Women International, 25, pp. 933-949.
6. Baddoura, R. and Wehbeh-Chidiac, C. (2001) Prevalence of tobacco use among the adult Lebanese population. Eastern Mediterranean Health. Journal, 7, pp. 819-828.
7. Bonaa, K. H., Njolstad, I. Ueland, P. M. et al. (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. The New England Journal of Medicine, 354:15, pp. 1578-1588.
8. Boushey, C. J., Beresford, S. A. Omenn, G. S. et al. (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes. JAMA, 274, pp. 1049-1057.
9. De Bree, A., Verschuren, W. M., Kromhout, D., Kluijtmans, L. A. and Blom, H. J. (2002) Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacological Reviews, 54, pp. 599-618.
10. Diakoumopoulou, E., Tentolouris, N., Kirlaki, E., Perrea, D., Kitsou, E. Psallas, M. et al. (2005) Plasma homocysteine levels in patients with type 2 diabetes in a Mediterranean population: Relation with nutritional and other factors. Nutrition, Metabolism and Cardiovascular Disease, 15, pp. 109-117.
11. Doshy, S. N., McDowell, I. F., Moat, S. J., Payne, N., Durrant, H. J., Lewis, M. J. and Goodfellow, J. (2002) Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation, 105, pp. 22-26.
12. Fakhrzadeh, H., Ghotbi, S., Pourebrahim, R., Nouri, M., Heshmat, R. Bandarian, F. et al. (2006) Total plasma homocysteine, folate, and vitamin b12 status in healthy Iranians adults: The Tehran homocysteine survey (2003-2004)/a cross-sectional population based study. BMC public health, 6, pp. 29-37.
13. Folsom, A. R., Nieto, F. J., McGovern, P. G., Tsai, M. Y., Malinow, M. R. Eckfeldt, J. H. et al. (1998) Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins. The Atherosclerosis risk in communities (ARIC) study. Circulation, 98, pp. 204-210.
14. Garber, A. M., Browner, W. S. and Hulley, S. B. (1996) Cholesterol screening in asymptomatic adults, revisited. Annals of Internal Medicine, 124, pp. 518-531.
15. Gielchinsky, Y., Elstein, D., Green, R., Miller, J. W., Elstein, Y. Algur, N. et al. (2001) High prevalence of low serum vitamin B12 in a multi-ethnic Israeli population. British Journal of Haematology, 115, pp. 707-709.
16. Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs Jr, D. R., Bangdiwala, S. and Tyroler, H. A. (1989) High-density lipoprotein cholesterol and cardiovascular disease: Four prospective American studies. Circulation, 79, pp. 8-15.
17. Herrmann, W., Obeid, R. and Jouma, M. (2003) Hyperhomocysteinemia and vitamin B-12 deficiency are more striking in Syrians than in Germans-causes and implications. Atherosclerosis, 166, pp. 143-150.
18. Hokanson, J. E. and Austin, M. A. (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population based prospective studies. Journal of Cardiovascular Risk, 3, pp. 213-219.
19. Homocysteine, Lowering Trialists' Collaboration (1998) Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomized trials. British Medical Journal, 316, pp. 894-898.
20. Homocysteine, Studies Collaboration (2002) Homocysteine and risk if ischemic heart disease and stroke. Journal of American Medical Association, 288, pp. 2015-2022.
21. Iglseder, B., Cip, P., Malaimare, L., Ladurner, G. and Paulweber, B. (2005) The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke, 36, pp. 1212-1217.
22. Jafar, T. H. (2006) Women in Pakistan have a greater burden of clinical cardiovascular risk factors than men. International Journal of Cardiology, 106, pp. 348-354.
23. Khader, Y., Bateiha, A., El-Khateed, M., Al-Sheikh, A. and Ajlouni, K. (2007) High prevalence of the metabolic syndrome among Northern Jordanians. Journal of Diabetes and its complications, 21, pp. 214-219.
24. Khasawneh, N. F., Al-Safi, S., Albsoul-Younes, A. and Borqan, O. N. (2005) Clustering of coronary artery disease risk factors in Jordanian hypertensive patients. Saudi Medical Journal, 26, pp. 215-219.
25. Kuulasmaa, K., Tunstall-Pedoe, H. Dobson, A. et al. (2000) Estimation of contribution of changes in classic risk factors to trends in coronary event-rates across the WHO MONICA Project populations. Lancet, 355, pp. 675-687.
26. Laing, S. P., Swerdlow, A. J. Slater, S. D. et al. (1999) The British Diabetic Association Cohort Study, II: Cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabetic Medicine, 16, pp. 466-471.
27. Lin, P. T., Cheng, C. H., Liaw, Y. P., Lee, B. J., Lee, T. W. and Huang, Y. C. (2006) Low pyridoxal 5-phosphate is associated with increased risk of coronary artery disease. Nutrition, 22, pp. 1146-1151.
28. Mangoni, A. A. and Jackson, S. H. D. (2002) Homocysteine and Cardiovascular Disease: Current Evidence and Future Prospects. American Journal of Medicine, 112, pp. 556-565.
29. Maron, D. J. (2000) The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease. American Journal of Cardiology, 86, pp. 11L-14L.
30. McCully, K. S. (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. American Journal of Pathology, 56, pp. 111-128.
31. McKinley, M., McNulty, H., McPartlin, J., Strain, J. J., Pentieva, K., Ward, M., Weir, D. G. and Scott, J. (2001) Low-dose vitamin B6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. American Journal of Clinical Nutrition, 73, pp. 759-764.
32. Mizrahi, E. H., Bouwirrat, A., Jacobsen, D. W., Korczyn, A. D., Traore, F. Petot, G. J. et al. (2004) Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel. Journal of Neurological Sciences, 227, pp. 109-113.
33. Onat, A., Hergenc, G., Turkmen, S., Yazici, M., Sari, I. and Can, G. (2006) Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation. Metabolism, 55, pp. 445-452.
34. Sauberlich, H. E. (1999) Laboratory tests for the Assessment of Nutritional Status, CRC Press, Florida
35. Stangl, V., Baumann, G. and Stangl, K. (2002) Coronary atherogenic risk factors in women. European Heart Journal, 23, pp. 1738-1752.
36. te Poele-Pothoff, M. T. W. B., van den Berg, M., Franken, D. G., Boers, G. H. J., Jakobs, C. de Kroom, I. F. I. et al. (1995) Three different methods for the determination of total homocysteine in plasma. Annals of Clinical Biochemistry, 32, pp. 218-220.
37. The Heart Outcome Prevention Evaluation (HOPE) 2 investigators, (2006) Homocysteine lowering with folate and B vitamins in vascular disease. The New England Journal of Medicine, 354:15, pp. 1567-1577.
38. Wald, D. S., Law, M. and Morris, J. K. (2002) Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. British Medical Journal, 325, p. 1202.
39. Willett, W. C., Manson, J. E. Stampfer, M. J. et al. (1995) Weight, weight change, and coronary heart disease in women. JAMA, 273, pp. 461-465.
40. Watson, K. E. and Topol, E. J. (2004) Pathobiology of atherosclerosis: are there racial and ethnic difference?. Reviews in Cardiovascular Medicine, 5, pp. S14-S2.